CS252340B1 - 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative - Google Patents
4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative Download PDFInfo
- Publication number
- CS252340B1 CS252340B1 CS863351A CS335186A CS252340B1 CS 252340 B1 CS252340 B1 CS 252340B1 CS 863351 A CS863351 A CS 863351A CS 335186 A CS335186 A CS 335186A CS 252340 B1 CS252340 B1 CS 252340B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- methyl
- pyrazolo
- quinoline
- chloro
- methoxy
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
ŘeSení se týká 4-chlor-6methoxy- -3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N -methylderivétu obecného vzorce I Cl R kde R je atom vodíku nebo methylskupina. Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.The solution relates to 4-chloro-6methoxy-3-methyl-1H-pyrazolo[3,4-b]quinoline and its N-methyl derivative of the general formula I Cl R where R is a hydrogen atom or a methyl group. These new, previously undescribed substances are useful as intermediates for the preparation of substances exhibiting significant biological effects, in particular antiviral and antitumor effects.
Description
ŘeSení se týká 4-chlor-6methoxy-3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N -methylderivétu obecného vzorce IThe invention relates to 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline and its N-methyl derivative of the general formula I
ClCl
R kde R je atom vodíku nebo methylskupina. Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.Wherein R is hydrogen or methyl. These novel substances, which have not been described yet, are useful as intermediates for the preparation of substances having significant biological effects, in particular antiviral and antitumor activity.
Vynález ae týká 4-chlor-6-meth9xy-3-methyl-1H-pyrazolo/3,4-b/chinolinu a jeho N’-methylderivátu obecného vzorce IThe invention relates to 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline and its N'-methyl derivative of the formula I
kde H je atom vodíku nebo methylakupina.wherein H is hydrogen or methyl.
Tyto nové, dosud nepopsané látky, jsou použitelné jako meziprodukty pro přípravu látek vykazujících významné biologické účinky, zejména protivirový a protinádorový účinek.These novel substances, which have not been described yet, are useful as intermediates for the preparation of substances having significant biological effects, in particular antiviral and antitumor activity.
Sloučeninu obecného vzorce I, kde R je atom vodíku, lze podle vynálezu připravit cyklizací 3-(4-methoxyanilino)-5-methyl-1H-pyrazol-4-karboxylové kyseliny oxidochloridetn fosforečným. Sloučeninu obecného vzorce I, kde H je methylakupina, lze podle vynálezu připrevit methylací sloučeniny obecného vzorce I, kde R je atom vodíku, dimethylsulfátem v přítomnosti práškového hydroxidu draselného v prostředí aprotického rozpouštědle, výhodně v dimethylsulfoxidu, za teploty místnosti.The compound of formula I wherein R is hydrogen may be prepared according to the invention by cyclizing 3- (4-methoxyanilino) -5-methyl-1H-pyrazole-4-carboxylic acid with phosphorous oxychloride. According to the invention, a compound of formula I wherein H is methyl may be prepared by methylating a compound of formula I wherein R is hydrogen with dimethyl sulfate in the presence of powdered potassium hydroxide in an aprotic solvent environment, preferably dimethylsulfoxide, at room temperature.
Způsob přípravy látek je jednoduchý a poskytuje žádané látky v uspokojivých výtěžcích. Bližší podrobnosti vyplývají z. následujících příkladů provedení. Uvedené příklady tento vynélez pouze ilustrují, nikoliv omezují.The process for preparing the substances is simple and provides the desired substances in satisfactory yields. Further details can be found in the following examples. These examples are merely illustrative and not limiting.
PřikladlHe did
4-chlor-6-methoxy-3-raethyl-1H-pyrazolo/3,4-b/chinolin4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline
Směs 3-(4-methoxyenilino)-5-raethyl-1íi-pyrazol-4-karboxylové kyseliny (4,5 g, 18 mmol) a oxidochloridu fosforečného (40 ml) byla vařena pod zpětným chladičem 1 hodinu. Sirupovitý zbytek získaný oddestilování® přebytku oxidochloridu fosforečného byl nalit na led a směs byla zalkalizována 4M roztokem hydroxidu sodného. Po ochlazení byl nerozpustný podíl odsát a promyt vodou. -<rystalizaci z chloroformu bylo získáno 4,25 g (94 ») žlutých krystalů o t.t. 232 až 236 °C.A mixture of 3- (4-methoxyenilino) -5-methyl-1 H -pyrazole-4-carboxylic acid (4.5 g, 18 mmol) and phosphorus pentoxide (40 mL) was refluxed for 1 hour. The syrupy residue obtained by distilling the excess phosphorus pentoxide was poured onto ice and basified with 4M sodium hydroxide solution. After cooling, the insoluble matter was aspirated and washed with water. Crystallization from chloroform gave 4.25 g (94%) of yellow crystals of m.p. Mp 232-236 ° C.
Přiklad 2Example 2
4-chlor-6-methoxy-1,3-dimethyl-1H-pyrazolo/3,4-b/chinolin4-chloro-6-methoxy-1,3-dimethyl-1H-pyrazolo [3,4-b] quinoline
K suspenzi 4-chlor-6-methcxy-3-methyl-1H-pyrazolo/3,4-b/chinolinu (9,9 g, 40 nuaol) v dimethylsulfoxidu (100 ml) byl přidán práškový hydroxid draselný (2,5 g 45 mmol) a směs byla míchána 4 hodiny za teploty místnosti. Potom byl přidán dimethylsulfát (5,6 g, 45 mmol) a směs byla míchána 8 hodin za teploty místnosti. Směs byla vlita do vody, vyloučená látka byla odsáta a promyta vodou. Surový produkt byl čiětěn vakuovou sublimací. Bylo získáno 8,0 g látky (76 ié) o t.t. 128 až 133 °C.To a suspension of 4-chloro-6-methoxy-3-methyl-1H-pyrazolo [3,4-b] quinoline (9.9 g, 40 nuaol) in dimethylsulfoxide (100 mL) was added powdered potassium hydroxide (2.5 g). 45 mmol) and the mixture was stirred at room temperature for 4 hours. Dimethyl sulfate (5.6 g, 45 mmol) was then added and the mixture was stirred at room temperature for 8 hours. The mixture was poured into water, the precipitate was filtered off with suction and washed with water. The crude product was clarified by vacuum sublimation. 8.0 g (76%) of m.p. Mp 128-133 ° C.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS863351A CS252340B1 (en) | 1986-05-08 | 1986-05-08 | 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS863351A CS252340B1 (en) | 1986-05-08 | 1986-05-08 | 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS335186A1 CS335186A1 (en) | 1987-01-15 |
| CS252340B1 true CS252340B1 (en) | 1987-08-13 |
Family
ID=5373293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS863351A CS252340B1 (en) | 1986-05-08 | 1986-05-08 | 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS252340B1 (en) |
-
1986
- 1986-05-08 CS CS863351A patent/CS252340B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS335186A1 (en) | 1987-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870000441B1 (en) | Process for preparing 7- amino 1- cyclopropyl -4- oxo -1,4 - dihydro - naphthridine -3- carboxylic acids | |
| PL192461B1 (en) | Method of obtaining 8-methoxy-quinolinocarboxylic acids | |
| NO842684L (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLE DERIVATIVES | |
| CA2368815A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| USRE31429E (en) | Process for preparation of 9-(dihalobenzyl)adenines | |
| US4072680A (en) | Derivatives of pyrazolo[1,5-a]pyrido[3,2-e]pyrimidine | |
| CS252340B1 (en) | 4-chloro-6-methoxy-3-methyl-1H-pyrazolo (3,4-b) quinoline and its Np-methyl derivative | |
| KR20020041421A (en) | Process for production of naphthyridine-3-carboxylic acid derivatives | |
| HRP20010759A2 (en) | Novel synthesis of piperazine ring | |
| US6576764B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
| KR20120100977A (en) | Method for the synthesis of 2-thiohistidine and the like | |
| US5321137A (en) | Process for the preparation of imidazopyridines | |
| GB2171995A (en) | Pharmaceutically active 8-heteroarylthio-5, 6, 7, 8-tetrahydroquinolines | |
| US3929789A (en) | Pyrimidinyl acetic acid derivatives and processes for their production | |
| US4031103A (en) | 1,8-Naphthyridine compounds | |
| US4060527A (en) | Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives | |
| CA1162543A (en) | Process for the preparation of apovincaminic acid esters | |
| US20040176591A1 (en) | Novel synthesis and crystallization of peperazine ring-containing compounds | |
| KR840000522B1 (en) | Process for preparation of quinoline derivatives | |
| EP0149537B1 (en) | Process for the synthesis of aminonitropyridines | |
| CS252341B1 (en) | 0.N-substituted 4,9-dihydro-6-hydroxy-1,3-dimathyl-4-oxo-1H-pyrazolo (3,4-b) quinolines | |
| US4080326A (en) | Acetic acid derivatives and processes for their production | |
| CS277411B6 (en) | Novel esters of beta-carboline-3-carboxylic acids being substituted in position 5 or 6 | |
| US4098787A (en) | Process for preparation of 9-(dihalobenzyl) adenines | |
| US4137411A (en) | Preparation of 2,4-diamino-5-(4-amino-3,5-substituted-benzyl)-pyrimidines |